Detection and evaluation of signals associated with exposure to individual and combination of medications in pregnancy: a signal detection study protocol
Open Access
Abstract
Introduction Considering the high prevalence of polypharmacy in pregnant women and the knowledge gap in the risk–benefit safety profile of their often-complex treatment plan, more research is needed to optimise prescribing. In this study, we aim to detect adverse and protective effect signals of exposure to individual and pairwise combinations of medications during pregnancy. Methods and analysis Using a range of real-world data sources from the UK, we aim to conduct a pharmacovigilance study to assess the safety of medications prescribed during the preconception period (3 months prior to conception) and first trimester of pregnancy. Women aged between 15 and 49 years with a record of pregnancy within the Clinical Practice Research Datalink (CPRD) Pregnancy Register, the Welsh Secure Anonymised Information Linkage (SAIL), the Scottish Morbidity Record (SMR) data sets and the Northern Ireland Maternity System (NIMATS) will be included. A series of case control studies will be conducted to estimate measures of disproportionality, detecting signals of association between a range of pregnancy outcomes and exposure to individual and combinations of medications. A multidisciplinary expert team will be invited to a signal detection workshop. By employing a structured framework, signals will be transparently assessed by each member of the team using a questionnaire appraising the signals on aspects of temporality, selection, time and measurement-related biases and confounding by underlying disease or comedications. Through group discussion, the expert team will reach consensus on each of the medication exposure–outcome signal, thereby excluding spurious signals, leaving signals suggestive of causal associations for further evaluation. Ethics and dissemination Ethical approval has been obtained from the Independent Scientific Advisory Committee, SAIL Information Governance Review Panel, University of St. Andrews Teaching and Research Ethics Committee and Office for Research Ethics Committees Northern Ireland (ORECNI) for access and use of CPRD, SAIL, SMR and NIMATS data, respectively.Keywords
Funding Information
- Medical Research Council (MR/W014432/1)
This publication has 22 references indexed in Scilit:
- Reported adverse drug reactions in women and men: Aggregated evidence from globally collected individual case reports during half a centuryeClinicalMedicine, 2019
- Methods to generate and validate a Pregnancy Register in the UK Clinical Practice Research Datalink primary care databasePharmacoepidemiology and Drug Safety, 2019
- Use of real‐world evidence from healthcare utilization data to evaluate drug safety during pregnancyPharmacoepidemiology and Drug Safety, 2019
- Getting through the day: a pilot qualitative study of U.S. women’s experiences making decisions about anti-nausea medication during pregnancyBMC Pregnancy and Childbirth, 2018
- Evaluation of maternal medications and diseases recorded in Northern Ireland Maternity System (NIMATS) database compared to NI Enhanced Prescribing Database (EPD): a data linkage validation studyInternational Journal of Population Data Science, 2018
- Making Decisions About Medication Use During Pregnancy: Implications for Communication StrategiesMaternal and Child Health Journal, 2017
- Data Resource Profile: Clinical Practice Research Datalink (CPRD)International Journal of Epidemiology, 2015
- Structured Assessment for Prospective Identification of Safety Signals in Electronic Medical Records: Evaluation in the Health Improvement NetworkDrug Safety, 2014
- Pilot evaluation of an automated method to decrease false‐positive signals induced by co‐prescriptions in spontaneous reporting databasesPharmacoepidemiology and Drug Safety, 2013
- Recent Patterns of Medication Use in the Ambulatory Adult Population of the United StatesJAMA, 2002